Pre-release: this release has not been published. Identifiers are permanent; descriptions may still change.

HB 5260 (2023-2024)

https://ontology.bommaritollc.com/id/01a0d568-bdda-7652-9483-317ee4def68f

adms:identifier	mi-legislature-measure 2023-2024/HB/5260
dcterms:temporal	Michigan Legislature, 2023-2024 session
primary sponsor	John R. Roth
prov:wasDerivedFrom	evidence from https://www.legislature.mi.gov/Bills/Bill?ObjectName=2023-HB-5260 evidence from https://www.legislature.mi.gov/Bills/Bill?ObjectName=2023-HB-5260 evidence from https://www.legislature.mi.gov/Bills/Bill?ObjectName=2023-HB-5260 evidence from https://www.legislature.mi.gov/Bills/Bill?ObjectName=2023-HB-5260
schema:legislationChanges	1978 PA 368
schema:legislationIdentifier	HB 5260
schema:legislationJurisdiction	Michigan
schema:legislationType	bill
schema:name	Health: pharmaceuticals; authority to prescribe off-label prescriptions; provide for. Amends 1978 PA 368 (MCL 333.1101 - 333.25211 ) by adding sec. 17773.en
schema:sponsor	William Bruck Steve Carra Brad Paquette Rachelle Smit Joseph A. Aragona Alicia St. Germaine Jay DeBoyer Jaime Greene Brian BeGole Gina Johnsen Angela Rigas John R. Roth Ken Borton Robert Bezotte
schema:url	https://www.legislature.mi.gov/Bills/Bill?ObjectName=2023-HB-5260
skos:prefLabel	HB 5260 (2023-2024)en
status	in committee
status date	2023-10-26xsd:date